Canada Launches Sogroya as the First Weekly Growth Hormone Therapy for GHD Canada has welcomed Sogroya® (somapacitan injection) as a new, once-weekly option for children and adults living with growth hormone deficiency (GHD). This landmark approval marks the first and only regimen of its kind that reduces the frequency of injections while delivering effective growth…